Monte Rosa Therapeutics Inc
Ownership
Ownership Structure
Who owns Monte Rosa Therapeutics Inc (GLUE)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 63.9% of the shares are freely tradable; institutional investors hold 113.2%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| T. Rowe Price Associates, Inc. | 11.28 | 8,861,171 | +31.9 | 06/30/2026 |
| NEA Management Company, LLC | 9.79 | 7,692,298 | +0.0 | 06/30/2026 |
| BlackRock Inc | 8.71 | 6,843,087 | +21.4 | 06/30/2026 |
| TCG Crossover Management, LLC | 5.88 | 4,622,151 | +0.0 | 06/30/2026 |
| Vestal Point Capital LP | 5.86 | 4,600,000 | +27.7 | 06/30/2026 |
| Bvf Inc | 5.68 | 4,460,886 | +0.0 | 06/30/2026 |
| Baker Bros Advisors LP | 5.53 | 4,345,736 | +0.0 | 06/30/2026 |
| State Street Corp | 4.75 | 3,731,416 | +11.3 | 06/30/2026 |
| Suvretta Capital Management, LLC | 4.52 | 3,549,539 | -16.0 | 06/30/2026 |
| Vanguard Capital Management, LLC | 4.35 | 3,412,927 | +10.1 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Warmuth Markus | President & CEO | 585,038 | 6,318,410 $ | Jul 16, 2026 | direct |
| Champoux Jennifer | Chief Operating Officer | 62,371 | 673,607 $ | Jul 15, 2026 | direct |
| Bowen Matthew | Principal Accounting Officer | 25,891 | 279,623 $ | Oct 5, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 5, 2026 | Bowen Matthew | Principal Accounting Officer | Sell | 13 | 10.56 | 137 |
| Jul 16, 2026 | Warmuth Markus | President & CEO | Sell | 9,500 | 23.18 | 220,219 |
| Jul 15, 2026 | Champoux Jennifer | Chief Operating Officer | Sell | 4,351 | 23.38 | 101,730 |
| Jul 15, 2026 | Champoux Jennifer | Chief Operating Officer | Other | 4,351 | 3.98 | 17,317 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.